Start the conversation
Michael Robinson has never been afraid to make public predictions.
And he has a track record of being right.
This is premium content for Private Briefing subscribers only.
Breaking News: The FDA Just Put Its "Seal of Approval" on Our Surging Medical Marijuana Biotech
Insys Therapeutics Inc. (NASDAQ: INSY) – our “War on Pain” biotech play – has given us a profit of more than 16% since we recommended the stock just two weeks ago.